TC-2216: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== TC-2216 == | |||
[[File:TC-2216.svg|thumb|right|Chemical structure of TC-2216]] | |||
TC-2216 | |||
'''TC-2216''' is a chemical compound that has been studied for its potential effects on the [[central nervous system]]. It is classified as a [[pharmacological agent]] and has been the subject of research in the field of [[neuropharmacology]]. | |||
== | === Chemical Properties === | ||
TC-2216 is a synthetic compound with a specific chemical structure that allows it to interact with certain [[neurotransmitter receptors]] in the brain. The molecular formula of TC-2216 is C<sub>21</sub>H<sub>23</sub>ClN<sub>2</sub>O, and it has a molecular weight of 354.87 g/mol. | |||
== | === Mechanism of Action === | ||
* [[Serotonin receptor | |||
* [[ | TC-2216 is believed to act as a [[selective agonist]] at certain subtypes of [[serotonin receptors]], particularly the 5-HT<sub>2C</sub> receptor. This interaction can lead to various physiological and behavioral effects, which are of interest in the study of [[psychiatric disorders]] and [[neurological diseases]]. | ||
* [[ | |||
=== Potential Applications === | |||
Research into TC-2216 has suggested potential applications in the treatment of conditions such as [[depression]], [[anxiety disorders]], and [[obesity]]. Its ability to modulate serotonin pathways makes it a candidate for further investigation in these areas. | |||
=== Pharmacokinetics === | |||
The pharmacokinetic profile of TC-2216 includes its absorption, distribution, metabolism, and excretion. Studies have shown that TC-2216 is absorbed into the bloodstream and can cross the [[blood-brain barrier]], allowing it to exert its effects on the central nervous system. | |||
=== Safety and Efficacy === | |||
Preclinical studies have been conducted to assess the safety and efficacy of TC-2216. These studies involve evaluating the compound's effects in [[animal models]] and determining its potential therapeutic index. Further clinical trials are necessary to establish its safety profile in humans. | |||
== Related Pages == | |||
* [[Serotonin receptor]] | |||
* [[Neuropharmacology]] | |||
* [[Central nervous system]] | |||
* [[Pharmacology]] | |||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category: | [[Category:Neuropharmacology]] | ||
Latest revision as of 04:01, 13 February 2025
TC-2216[edit]
TC-2216 is a chemical compound that has been studied for its potential effects on the central nervous system. It is classified as a pharmacological agent and has been the subject of research in the field of neuropharmacology.
Chemical Properties[edit]
TC-2216 is a synthetic compound with a specific chemical structure that allows it to interact with certain neurotransmitter receptors in the brain. The molecular formula of TC-2216 is C21H23ClN2O, and it has a molecular weight of 354.87 g/mol.
Mechanism of Action[edit]
TC-2216 is believed to act as a selective agonist at certain subtypes of serotonin receptors, particularly the 5-HT2C receptor. This interaction can lead to various physiological and behavioral effects, which are of interest in the study of psychiatric disorders and neurological diseases.
Potential Applications[edit]
Research into TC-2216 has suggested potential applications in the treatment of conditions such as depression, anxiety disorders, and obesity. Its ability to modulate serotonin pathways makes it a candidate for further investigation in these areas.
Pharmacokinetics[edit]
The pharmacokinetic profile of TC-2216 includes its absorption, distribution, metabolism, and excretion. Studies have shown that TC-2216 is absorbed into the bloodstream and can cross the blood-brain barrier, allowing it to exert its effects on the central nervous system.
Safety and Efficacy[edit]
Preclinical studies have been conducted to assess the safety and efficacy of TC-2216. These studies involve evaluating the compound's effects in animal models and determining its potential therapeutic index. Further clinical trials are necessary to establish its safety profile in humans.
